drugset / Trial / NCT00390689
A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of double blind phase in this trial is to compare the efficacy and safety at the fixed dose of 0.25 mg,0.5 mg and 0.75 mg pramipexole in RLS. The objective of open label phase in this trial is to investigate the long term safety and efficacy of pramipexole in RLS.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 0.25 mg | — |
| Subject | Pramipexole | Unknown | 0.5 mg | — |
| Subject | Pramipexole | Unknown | 0.75 mg | — |